News

UCL scientists will be developing an AI platform which could one day help researchers identify new treatments for illnesses such as lung and liver diseases, as part of a new international consortium.

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid fatigue among people receiving care from specialist long Covid clinics, according to new findings from a large clinical trial led by UCL and UCLH.

A startup co-developed by a UCL alumnus has taken part in the sought-after Y Combinator accelerator in San Francisco to develop its AI personal health assistant for people living with chronic illness.

Social prescribing, which connects people to arts and exercise activities and other sources of support, may help adolescents waiting for specialist mental health services by improving their resilience, behaviour and relationships with others, suggests a new study by a UCL team.

UCL has awarded Helen Matthews, CEO of the Cure Parkinson’s charity, an honorary fellowship, recognising two decades of work that has helped reshape the global Parkinson's research landscape. 

A major new UCL-led innovation hub aims to transform how children with complex health needs are supported at key moments in their lives – such as starting school or returning home from hospital – by addressing the system gaps that families say cause the most disruption.

A major new resource that provides one of the most comprehensive pictures yet of what people are eating around the world has been introduced in a new study by a UCL and University of Oxford researcher.

This week we chat to Dr Hélène Crutzen, Institute Manager at the Queen Square Institute of Neurology. Read about the Institute of Neurology's 75th anniversary, developing strategy, and a milestone to look forward to beyond our 200th year.

UCL Queen Square Institute of Neurology is marking 75 years of pioneering research, innovation and education, coinciding with UCL’s bicentennial year.

A form of CAR T cell therapy can find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, in new research led by UCL and University of Oxford researchers.

Ten weeks of cognitive rehabilitation can help people with long Covid symptoms such as brain fog achieve their goals in returning to work and hobbies, finds a new clinical trial led by UCL researchers.

“Supporting carers is not simply about recognising their contribution; it is about ensuring that caregiving remains at a level that is sustainable for carers’ health and wellbeing,” Dr Baowen Xue (UCL Institute of Epidemiology and Health Care) writes in Public Sector Service.

A special partnership between UCL and a Japanese pharmaceutical firm which is investigating new treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s has been extended to 2030.

The development of a pioneering gene therapy to treat a devastating, rare immune disorder led by UCL scientists is set to move into its next phase following promising early pre-clinical studies.

Two UCL-led exhibits featuring dinosaur skulls, chameleon heads, and tiny materials transforming healthcare are among 13 flagship displays open to the public at the 2026 Royal Society Summer Science Exhibition.